Thursday, April 19, 2018

First-Ever Peer-Reviewed Study of Vaccinated vs Unvaccinated Children Shows Vaccinated Kids Have a Higher Rate of Sickness, 470% Increase in Autism (PAST RESEARCH ON MERCK & VACCINES)


First-Ever Peer-Reviewed Study of Vaccinated vs Unvaccinated Children Shows Vaccinated Kids Have a Higher Rate of Sickness, 470% Increase in Autism (PAST RESEARCH ON MERCK & VACCINES)
Wednesday, May 10, 2017
May 7, 2017 Mark Blaxill, Age of Autism Health 9
Pilot Comparative Study on the Health of Vaccinated and Unvaccinated 6-12 Year Old US Children

In a development that autism parents have long anticipated, the first-ever, peer-reviewed study comparing total health outcomes in vaccinated and unvaccinated children was released on line yesterday. According to sources close to the project, the study had been reviewed and accepted by two different journals, both of which pulled back on their approval once the political implications of the findings became clear. That’s largely because, as parents have long expected, the rate of autism is significantly higher in the vaccinated group, a finding that could shake vaccine safety claims just as the first president who has ever stated a belief in a link between vaccines and autism has taken office.

Working in partnership with the National Home Education Research Institute (NHERI), Dr. Anthony Mawson led a research team that investigated the relationship between vaccination exposures and a range of over 40 acute and chronic illnesses in home schooled children, a population chosen for its high proportion of unvaccinated children. Surveying families in four states–Florida, Louisiana, Mississippi and Oregon—the study (officially titled Vaccination and Health Outcomes: A Survey of 6- to 12-year-old Vaccinated and Unvaccinated Children based on Mothers’ Reports), reported a number of startling findings.

Vaccinated children were significantly more likely than the unvaccinated to have been diagnosed with a neurodevelopmental disorder: most notably, the risk of being affected by an Autism Spectrum Disorder (ASD) was 4.7 fold higher in vaccinated children; as well, ADHD risk was 4.7 fold higher and learning disability risk was 3.7 fold higher. Overall, the vaccinated children in the study were 3.7 times more likely to have been diagnosed with some kind of neurodevelopmental disorder.

Vaccinated children were also significantly more likely to be diagnosed with an immune-related disorder. The risk of allergic rhinitis (commonly known as hay fever) was over 30 times higher in vaccinated children, while the risk of other allergies was increased 3.9 fold and the eczema risk was increased 2.4 fold.

With respect to acute illness and infectious disease the outcomes were in some respects surprising.  As might be expected, unvaccinated children were significantly (4-10 times) more likely to have come down with chicken pox, rubella or pertussis. Perhaps unexpectedly, the unvaccinated children were less likely to suffer from otitis media and pneumonia: vaccinated children had 3.8 times greater odds of a middle ear infection and 5.9 times greater odds of a bout with pneumonia.

The study was based on a survey with participants recruited in a process led by NHERI and coordinated through 84 state and local homeschool groups. The survey itself was, according to the authors, “nonbiased and neutrally worded.”

These findings in a study population of 666 children, 261 of whom (39%) were unvaccinated, are sure to stir controversy, in part because it is the first of its kind. The scientific literature on the long-term effects of the vaccination program is virtually silent. Most studies on the safety of vaccines only consider immediate or short-term effects. There was no obvious explanation for the differences in health outcomes observed between the vaccinated and unvaccinated groups of children other than vaccination itself.

The finding that vaccination is a significant risk for autism is the most explosive finding in the paper. For well over a decade, parents concerned that vaccines were involved in autism’s sharp rise have been calling for what has long been labelled the “vax/unvax” study. Public health officials such as Paul Offit have resisted these calls with claims that a comparative study of autism risk and other health outcomes in unvaccinated and vaccinated children would be retrospectively impossible and prospectively unethical.

Despite opposition from those like Offit, attempts to launch a formal vax/unvax study have been made for many years. In 2006, Congresswoman Carolyn Maloney (D, NY) authored what is now called Vaccine Safety Study Act. Said Maloney to the opponents, “Maybe someone in the medical establishment will show me why this study is a bad idea, but they haven’t done it yet.” In 2007, Generation Rescue (one of the Mawson study’s sponsors) retained a market research firm to undertake a similar survey (it is available on line and had similar findings but was never published in a scientific journal).

Less formal surveys focused on whether or not autism was present in the unvaccinated have also been undertaken in unusual populations, including the Amish and the patients of alternative health practitioners. Age of Autism founder Dan Olmsted investigated autism in the Amish, who vaccinate less frequently. Autism is rare among the Amish and the only autistic Amish children we discovered were also vaccinated. (Others reported cases in Amish children with birth defects, but not “idiopathic autism,” the kind that occurs in otherwise typical children who are the heart of the current epidemic). The late Mayer Eisenstein reported in his HomeFirst practice in Chicago that he delivered more than 15,000 babies at home, and thousands of them were never vaccinated. Of these unvaccinated children, none had autism.

The link between autism and vaccination became a hot topic in this year’s presidential election. Democratic candidate Hillary Clinton once tweeted ““The science is clear: The earth is round, the sky is blue, and #vaccineswork. Let’s protect all our kids. #GrandmothersKnowBest.” In contrast, President Donald Trump has long been outspoken about the likely connection between vaccines and autism. As early as 2007, Trump remarked, “When I was growing up, autism wasn’t really a factor. And now all of a sudden, it’s an epidemic. Everybody has their theory, and my theory is the shots. They’re getting these massive injections at one time. I think it’s the vaccinations.”


MMR vaccine
The MMR vaccine is generally administered to children around the age of one year, with a second dose before starting school (i.e. age 4/5). The second dose is a dose to produce immunity in the small number of persons (2–5%) who fail to develop measles immunity after the first dose.[3] In the United States, the vaccine was licensed in 1971 and the second dose was introduced in 1989.[4] It is widely used around the world; since introduction of its earliest versions in the 1970s, over 500 million doses have been used in over 60 countries. The vaccine is sold by Merck as M-M-R II, GlaxoSmithKline Biologicals as Priorix, Serum Institute of India as Tresivac, and Sanofi Pasteur as Trimovax.
It is usually considered a childhood vaccination. However, it is also recommended for use in some cases of adults with HIV.

Hillary Clinton
Hillary Rodham Clinton was a director at the Bill, Hillary & Chelsea Clinton Foundation.

Note: Chelsea V. Clinton is the vice chair for the Bill, Hillary & Chelsea Clinton Foundation.
William J. Clinton is the founder of the Bill, Hillary & Chelsea Clinton Foundation.
Merck was a funder for the Bill, Hillary & Chelsea Clinton Foundation.
Sanofi was a funder for the Bill, Hillary & Chelsea Clinton Foundation.
Sanofi Pasteur is a division of Sanofi.
Christopher A. Viehbacher was a CEO for Sanofi, and a director at GlaxoSmithKline plc.
James R. Murdoch was a director at GlaxoSmithKline plc, a funder for the Bill, Hillary & Chelsea Clinton Foundation, and is a governing board member for the Indian (India) School of Business.
John D. Coombe was the CFO for GlaxoSmithKline plc, and a director at HSBC Holdings plc.
James B. Comey was a director at the HSBC Holdings plc, and a director at the Federal Bureau of Investigation (FBI).
HSBC Holdings plc was a funder for the Bill, Hillary & Chelsea Clinton Foundation.
Open Society Foundations was a funder for the Bill, Hillary & Chelsea Clinton Foundation, the Atlantic Council of the United States (think tank), the Human Rights Watch, and the American Civil Liberties Union (ACLU).
George Soros is the founder & chairman for the Open Society Foundations, was the chairman for the Foundation to Promote Open Society, and a benefactor for the Human Rights Watch.
Foundation to Promote Open Society was a funder for the Human Rights Watch, the International Rescue Committee, and the American Civil Liberties Union (ACLU).
John J. Studzinski is a director at the Atlantic Council of the United States (think tank), a director at the Human Rights Watch, the vice chairman for the Blackstone Group, and was a co-head of investment banking for HSBC Holdings plc.
Blackstone Group was a funder for the Bill, Hillary & Chelsea Clinton Foundation.
HSBC Holdings plc was a funder for the Bill, Hillary & Chelsea Clinton Foundation.
Hillary Rodham Clinton was a director at the Bill, Hillary & Chelsea Clinton Foundation.
Chelsea V. Clinton is the vice chair for the Bill, Hillary & Chelsea Clinton Foundation.
William J. Clinton is the founder of the Bill, Hillary & Chelsea Clinton Foundation.
Merck was a funder for the Bill, Hillary & Chelsea Clinton Foundation.
Sanofi was a funder for the Bill, Hillary & Chelsea Clinton Foundation.
Sanofi Pasteur is a division of Sanofi.
James R. Murdoch was a director at GlaxoSmithKline plc, a funder for the Bill, Hillary & Chelsea Clinton Foundation, and is a governing board member for the Indian (India) School of Business.
John D. Coombe was the CFO for GlaxoSmithKline plc, and a director at HSBC Holdings plc.
Stuart A. Levey is a chief legal officer for HSBC Holdings plc, and was an undersecretary for terrorism, financial intelligence for the U.S. Department of the Treasury.
Timothy F. Geithner was a secretary for the U.S. Department of the Treasury, and is an overseer, director for the International Rescue Committee.
Andrew Robertson is an overseer at the International Rescue Committee, and a director at Autism Speaks.
Herbert Pardes is a director at Autism Speaks, and a director at the Markle Foundation.
Markle Task Force on National Security in the Information Age is a national-security project for the Markle Foundation.
Eric H. Holder Jr. is a member of the Markle Task Force on National Security in the Information Age, a partner at Covington & Burling LLP, and Merck was his client.
Covington & Burling LLP is the lobby firm for Merck, and was the lobby firm for the Ford Foundation.
Merck was a funder for the Bill, Hillary & Chelsea Clinton Foundation.
Sanofi was a funder for the Bill, Hillary & Chelsea Clinton Foundation.
Sanofi Pasteur is a division of Sanofi.
James R. Murdoch was a director at GlaxoSmithKline plc, a funder for the Bill, Hillary & Chelsea Clinton Foundation, and is a governing board member for the Indian (India) School of Business.
John D. Coombe was the CFO for GlaxoSmithKline plc, and a director at HSBC Holdings plc.
N.R. Narayana Murthy was a director at HSBC Holdings plc, and is a trustee at the Ford Foundation.
Anke A. Ehrhardt was a trustee at the Ford Foundation, and is a director at the HIV Center for Clinical and Behavioral Studies.
Ford Foundation was a funder for the Bill, Hillary & Chelsea Clinton Foundation, and the International Rescue Committee.
Andrew Robertson is an overseer at the International Rescue Committee, and a director at Autism Speaks.
Anthony D. Romero was a director of human rights for the Ford Foundation, and is an executive director for the American Civil Liberties Union (ACLU).
ACLU Comment on Trump Firing of FBI Director Comey
May 9, 2017
WASHINGTONAmerican Civil Liberties Union Executive Director Anthony D. Romero issued the following statement on the firing of FBI Director James Comey:

No comments: